Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study
Cyclin-dependent kinase (CDK)4/6-inhibitors with endocrine therapy represent the standard of treatment of hormone receptor-positive(HR+)/human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC). Gut microbiota seems to predict treatment...
Advances in the Microbiome, Immunity and Cancer interplay
Gut microbiome plays an important role in colorectal cancer (CRC) initiation, progression and response to different systemic therapies. On its turn, gut microbiome is influenced by host factors (race, sex, genetic predisposition, oxidative stress, metabolic and...
NCI-funded project to study role of gut microbiome in prostate cancer
The study builds on their recent collaboration with the laboratory of Andrea Alimonti, M.D., head of molecular oncology at the Institute of Oncology Research in Switzerland, about the role of microbiota in castration-resistant prostate cancer. This type of prostate...
